InvestorsHub Logo
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

Re: None

Thursday, 05/20/2010 6:35:01 PM

Thursday, May 20, 2010 6:35:01 PM

Post# of 80490
AP534 ASCO Abstract

57% of chronic phase CML pts with the T315I mutation achieved a complete cytogenetic response. Compelling results.

http://abstract.asco.org/AbstView_74_53232.html

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.